Taro Pharmaceutical GAAP EPS of $0.73, revenue of $143.26M
Taro Pharmaceutical press release (TARO): Q4 GAAP EPS of $0.73.Revenue of $143.26M (-3.4% Y|Y).
Taro Pharmaceutical GAAP EPS of $0.73, revenue of $143.26M
Taro Pharmaceutical press release (TARO): Q4 GAAP EPS of $0.73.Revenue of $143.26M (-3.4% Y|Y).